| ID | 1591 |
|---|
| No | 1591 |
|---|
| Brand Name | ALIDABRAFENIB |
|---|
| Ingredients | DABRAFENIB MESYLATE 75 MG |
|---|
| Dosage Form | CAPSULE |
|---|
| Primary Packaging | BOTTLE |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | 120 CAPSULES/BOTTLE |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | TO TREAT UNRESECTABLE OR METASTATIC MELANOMA PATIENTS WITH BRAF V600E MUTATION POSITIVITY, METASTATIC NON SMALL CELL LUNG CANCER CAUSED BY BRAF V600E |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL | NULL |
|---|
| Description | RED CAPSULE CONTAINS WHITE POWDER |
|---|
| Note | |
|---|
| License Owner | LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
|---|
| Manufacturer | LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
|---|
| Country | LAOS |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 10 L 1222/24 |
|---|
| FDD Registration Date | 31/10/2024 |
|---|
| Expiry Date | 30/10/2029 |
|---|
